Evidence map›Paper›PMID 29995221›Full record

ReviewJournal of clinical immunology2018

A Variety of Alu-Mediated Copy Number Variations Can Underlie IL-12Rβ1 Deficiency.

Jérémie Rosain, Carmen Oleaga-Quintas, Caroline Deswarte, Hannah Verdin, Stéphane Marot, Garyfallia Syridou, Mahboubeh Mansouri, S Alireza Mahdaviani, Edna Venegas-Montoya, Maria Tsolia and 29 more

Open access · greenAbstract readCase ReportsReview
In one paragraph

Review in Journal of clinical immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Fibrosing mediastinitis in a child with Mendelian susceptibility to mycobacterial disease possibly due to Bacillus Calmette-Guérin.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors at 15 institutions in 7 countries.

Jérémie RosainLaboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France.
Carmen Oleaga-QuintasLaboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France.
Caroline DeswarteLaboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France.
Hannah VerdinCenter for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium.
Stéphane MarotStudy Center for Primary Immunodeficiencies, AP-HP, Necker Hospital for Sick Children, Paris, France.
Garyfallia SyridouPediatric Infectious Diseases, Thriasio Hospital, Athens, Greece.
Mahboubeh MansouriDepartment of Allergy and Clinical Immunology, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
S Alireza MahdavianiPediatric Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Edna Venegas-MontoyaThe Immunodeficiencies Research Unit, National Institute of Pediatrics, Mexico City, Mexico.
Maria TsoliaSecond Department of Pediatrics, P. and A. Kyriakou Children's Hospital, National and Kapodistrian University of Athens (NKUA), Athens, Greece.
Mehrnaz MesdaghiDepartment of Allergy and Clinical Immunology, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Liudmyla ChernyshovaDepartment of Pediatric Infectious Diseases and Immunology, Shupyk National Medical Academy for Postgraduate Education, Kiev, Ukraine.
Yuriy StepanovskiyDepartment of Pediatric Infectious Diseases and Immunology, Shupyk National Medical Academy for Postgraduate Education, Kiev, Ukraine.
Nima ParvanehResearch Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
Davood MansouriDepartment of Internal Medicine, Division of Infectious Disease and Clinical Immunology, NRITLD, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Sigifredo Pedraza-SánchezUnit of Biochemistry, National Institute for Medical Sciences and Nutrition Salvador Zubiran (INCMNSZ), Mexico City, Mexico.
Anastasia BondarenkoDepartment of Pediatric Infectious Diseases and Immunology, Shupyk National Medical Academy for Postgraduate Education, Kiev, Ukraine.
Sara E Espinosa-PadillaThe Immunodeficiencies Research Unit, National Institute of Pediatrics, Mexico City, Mexico.
Marco A Yamazaki-NakashimadaDepartment of Clinical Immunology, National Institute of Pediatrics, Mexico City, Mexico.
Alejandro Nieto-PatlánLaboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France.
Gaspard KernerLaboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France.
Nathalie LambertStudy Center for Primary Immunodeficiencies, AP-HP, Necker Hospital for Sick Children, Paris, France.
Corinne JacquesStudy Center for Primary Immunodeficiencies, AP-HP, Necker Hospital for Sick Children, Paris, France.
Emilie CorvilainLaboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France.
Mélanie MigaudLaboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France.
Virginie GrandinStudy Center for Primary Immunodeficiencies, AP-HP, Necker Hospital for Sick Children, Paris, France.
María T HerreraDepartment of Microbiology Research, National Institute of Respiratory Diseases (INER), Mexico City, Mexico.
Fabienne Jabot-HaninLaboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France.
Stéphanie Boisson-DupuisLaboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France.
Capucine PicardImagine Institute, Paris Descartes University, Paris, France.
Patrick NitschkeBioinformatics Core Facility, Imagine Institute, SFR-Necker, INSERM UMR1163 and INSERM US24/CNRS UMS3633, Paris Descartes Sorbonne Paris Cite University, Paris, France.
Anne PuelLaboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France.
Frederic ToresBioinformatics Core Facility, Imagine Institute, SFR-Necker, INSERM UMR1163 and INSERM US24/CNRS UMS3633, Paris Descartes Sorbonne Paris Cite University, Paris, France.
Laurent AbelLaboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France.
Lizbeth Blancas-GaliciaThe Immunodeficiencies Research Unit, National Institute of Pediatrics, Mexico City, Mexico.
Elfride De BaereCenter for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium.
Christine Bole-FeysotGenomic Core Facility, INSERM UMR1163, SFR-Necker, Imagine Institute, Paris, France.
Jean-Laurent CasanovaLaboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France.
Jacinta BustamanteLaboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France. jacinta.bustamante@inserm.fr.
Assistance Publique – Hôpitaux de Paris · FRInserm · FRUniversité Paris Cité · FRInstitut des Maladies Génétiques Imagine · FRShahid Beheshti University of Medical Sciences · IRShupyk National Healthcare University of Ukraine · UAGhent University Hospital · BERockefeller University · USDélégation Paris 5 · FRInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXMasih Daneshvari Hospital · IRNational Institute of Genomic Medicine · MXPanagiotis & Aglaia Kyriakou Children's Hospital · GRTehran University of Medical Sciences · IRThriasio General Hospital of Elefsina · GR

Funding

Genome-Wide Dissection of Mendelian Susceptibility to Mycobacterial DiseaseR37AI095983 · NIAID · ROCKEFELLER UNIVERSITY · PI CASANOVA, JEAN-LAURENT · 2011 to 2020
$4.6M
Howard Hughes Medical InstituteNIAID NIH HHS R37 AI095983
6 · The paper itself

Abstract

purposeInborn errors of IFN-γ immunity underlie Mendelian susceptibility to mycobacterial disease (MSMD). Autosomal recessive complete IL-12Rβ1 deficiency is the most frequent genetic etiology of MSMD. Only two of the 84 known mutations are copy number variations (CNVs), identified in two of the 213 IL-12Rβ1-deficient patients and two of the 164 kindreds reported. These two CNVs are large deletions found in the heterozygous or homozygous state. We searched for novel families with IL-12Rβ1 deficiency due to CNVs.

methodsWe studied six MSMD patients from five unrelated kindreds displaying adverse reactions to BCG vaccination. Three of the patients also presented systemic salmonellosis, two had mucocutaneous candidiasis, and one had disseminated histoplasmosis. We searched for CNVs and other variations by IL12RB1-targeted next-generation sequencing (NGS).

resultsWe identified six new IL-12Rβ1-deficient patients with a complete loss of IL-12Rβ1 expression on phytohemagglutinin-activated T cells and/or EBV-transformed B cells. The cells of these patients did not respond to IL-12 and IL-23. Five different CNVs encompassing IL12RB1 (four deletions and one duplication) were identified in these patients by NGS coverage analysis, either in the homozygous state (n = 1) or in trans (n = 4) with a single-nucleotide variation (n = 3) or a small indel (n = 1). Seven of the nine mutations are novel. Interestingly, four of the five CNVs were predicted to be driven by nearby Alu elements, as well as the two previously reported large deletions. The IL12RB1 locus is actually enriched in Alu elements (44.7%), when compared with the rest of the genome (10.5%).

conclusionThe IL12RB1 locus is Alu-enriched and therefore prone to rearrangements at various positions. CNVs should be considered in the genetic diagnosis of IL-12Rβ1 deficiency.

Indexed as

Alu ElementsDNA Copy Number VariationsGenetic Association StudiesGenetic Predisposition to DiseaseAllelesBase SequenceChromosome MappingFemaleGene ExpressionHumansInterferon-gammaInterleukin-12 Receptor beta 1 SubunitMaleMutationMycobacterium InfectionsPedigreeInterferon-gammaInterleukin-12 Receptor beta 1 SubunitAlu elementsCopy number variationHistoplasmaIL-12Rβ1MycobacteriumSalmonella

Identifiers

PMID29995221
PMCPMC6329663
OpenAlexW2873677957

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.